Related references
Note: Only part of the references are listed.Effect of Immune Pressure on Hepatitis C Virus Evolution: Insights From a Single-Source Outbreak
Shahzma Merani et al.
HEPATOLOGY (2011)
Rapid Emergence of Telaprevir Resistant Hepatitis C Virus Strain from Wildtype Clone In Vivo
Nobuttiko Hiraga et al.
HEPATOLOGY (2011)
Molecular Epidemiology of Autochthonous Dengue Virus Strains Circulating in Mexico
Pilar Rivera-Osorio et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Interleukin-28B Genotyping by Melt-Mismatch Amplification Mutation Assay PCR Analysis Using Single Nucleotide Polymorphisms rs12979860 and rs8099917, a Useful Tool for Prediction of Therapy Response in Hepatitis C Patients
Salvador Fonseca-Coronado et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors
S. Franco et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic Infection
Sumathi Ramachandran et al.
JOURNAL OF VIROLOGY (2011)
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Future of hepatitis C therapy: development of direct-acting antivirals
Gregory J. Dore et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Sequential Bottlenecks Drive Viral Evolution in Early Acute Hepatitis C Virus Infection
Rowena A. Bull et al.
PLOS PATHOGENS (2011)
Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis
Seyed-Moayed Alavian et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Simultaneous Cocirculation of Both European Varicella-Zoster Virus Genotypes (E1 and E2) in Mexico City
Araceli Rodriguez-Castillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Individualisation of antiviral therapy for chronic hepatitis C
Narci C. Teoh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Tracking the Evolution of Multiple In Vitro Hepatitis C Virus Replicon Variants under Protease Inhibitor Selection Pressure by 454 Deep Sequencing
Thierry Verbinnen et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing
Gary P. Wang et al.
JOURNAL OF VIROLOGY (2010)
QIIME allows analysis of high-throughput community sequencing data
J. Gregory Caporaso et al.
NATURE METHODS (2010)
Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients
Simone Susser et al.
HEPATOLOGY (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epidemiology of hepatitis C virus infection
Miriam J. Alter
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
Christoph Sarrazin et al.
GASTROENTEROLOGY (2007)
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor - Reduced rna replication fitness and partial rescue by second-site mutations
MK Yi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Global burden of disease (GBD) for hepatitis C
Y Hutin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Share Paper
